Our in-house experts have experience across the full cell and gene therapy life-cycle. Not only are they hard at work breaking down barriers to commercialise therapies, they are writing and sharing their knowledge through databases, publications, whitepapers, scientific posters and a host of other resources. Browse through the latest releases and contact us if there is a specific topic you would like to see covered.
22 August 2017
Phacilitate SIG Automation: Rapporteur's Report
16 August 2017
Preclinical development of an automated injection device for intradermal delivery of a cell-based therapy
31 July 2017
The High Cost of High Tech Medicine: Planning Ahead for Market Access